2009
DOI: 10.1016/j.meegid.2009.01.012
|View full text |Cite
|
Sign up to set email alerts
|

High throughput identification of clinical isolates of Staphylococcus aureus using MALDI-TOF-MS of intact cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
40
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(46 citation statements)
references
References 21 publications
4
40
2
Order By: Relevance
“…In cell extracts, PSM␣2 (m/z 2,307) and PSM␣3 (m/z 2,636) were predominant. The delta-toxin at m/z 3,007 (formylated version) is one of the peaks that was frequently discovered in the early attempts at mass spectrometry of intact S. aureus cells (7,9,10,21). Most useful for typing was the fourth group of signals, which comprised the stress or hypothetical proteins that are present in multiple isoforms.…”
Section: Resultsmentioning
confidence: 99%
“…In cell extracts, PSM␣2 (m/z 2,307) and PSM␣3 (m/z 2,636) were predominant. The delta-toxin at m/z 3,007 (formylated version) is one of the peaks that was frequently discovered in the early attempts at mass spectrometry of intact S. aureus cells (7,9,10,21). Most useful for typing was the fourth group of signals, which comprised the stress or hypothetical proteins that are present in multiple isoforms.…”
Section: Resultsmentioning
confidence: 99%
“…This previous lack of identification was compounded by the high cost and time required for phenotypic tests, as well as the usual poor clinical significance of a majority of CoNS isolated from clinical specimens. Conversely, mass spectrometry is notably able to more accurately carry out S. aureus identification than when using slide or tube coagulase tests, and it is faster and cheaper than any current automated system using phenotypic tests (20,21).…”
Section: Discussionmentioning
confidence: 99%
“…Quality-controlled databases of reference spectra including many relevant micro-organisms were established from the first 'proof of principle' experiments to integrate this method into clinical laboratories. To date, several commercial databases and non-commercial approaches for bacterial identification have been evaluated (Carbonnelle et al, 2007;Friedrichs et al, 2007;Rajakaruna et al, 2009;Seng et al, 2009). Nevertheless, these experiments have varied, particularly with regard to the sample preparation protocols: either formic acid extraction or direct smear preparation.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, these experiments have varied, particularly with regard to the sample preparation protocols: either formic acid extraction or direct smear preparation. Moreover, the samples were measured with different mass spectrometer instruments and the spectra generated were compared with varying ranges of proteomic fingerprints (Friedrichs et al, 2007;Rajakaruna et al, 2009).…”
Section: Introductionmentioning
confidence: 99%